Skip to main content

Table 2 Incremental costs, effects, and cost-effectiveness of a vaccine with efficacy 50% compared with a mitigation strategy. All costs are in Euro. Costs and life-years refer to one individual

From: Was EU’s COVID-19 vaccine procurement strategy irrational? A re-analysis based on cost-effectiveness considerations

Lockdown costs

Subsidy

Vaccination costs

Total costs

Life-years gained

ICER

-3159.89

9.02

33.32

-3117.55

- 0.02

128,353.85

  1. ICER incremental cost-effectiveness ratio